levodopa has been researched along with Hemisensory Neglect in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, R; Katsumata, Y; Mimura, M; Yamaguchi, S | 1 |
Bachoud-Lévi, AC; Cleret de Langavant, L; Fénelon, G; Soulas, T; Trinkler, I | 1 |
Chen, R; Hoque, T; Nelson, AJ; Premji, A; Rai, N; Tommerdahl, M | 1 |
Auxiette, C; Chambres, P; Dalens, H; Derost, P; Durif, F; Jalenques, I; Lemaire, JJ; Marie Coulangeon, L; Marques, A; Mermillod, M; Mondillon, L; Musca, SC; Rieu, I; Ulla, M; Vidal, T | 1 |
Kim, HS; Lee, MS; Lyoo, CH | 1 |
Fuchs, G; Hahne, M; Klein, W; Müller, T; Schwarz, M | 1 |
Azulay, JP; Blin, O; Mestre, D; Pouget, J; Sangla, I; Serratrice, G; Van Den Brand, C | 1 |
Allen, DG; Brown, LK; Brown, SL; Guilmette, TJ; Mukand, JA; Tober, KL; Vandyck, WR | 1 |
Sicuteri, F | 1 |
Arbit, J; Blonsky, ER; Boshes, B; Dolkart, M; Kovach, JW | 1 |
Fischer, PA; Gundelsheimer, W; Jacobi, P; Schneider, E | 1 |
Ljungberg, T; Steg, G; Ungerstedt, U | 1 |
2 trial(s) available for levodopa and Hemisensory Neglect
Article | Year |
---|---|
The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Emotions; Facial Expression; Female; Frontal Lobe; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pattern Recognition, Visual; Perceptual Disorders; Subthalamic Nucleus | 2012 |
Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series.
Topics: Activities of Daily Living; Aged; Carbidopa; Dopamine Agents; Female; Geriatric Assessment; Humans; Levodopa; Perceptual Disorders; Severity of Illness Index; Stroke; Treatment Outcome | 2001 |
10 other study(ies) available for levodopa and Hemisensory Neglect
Article | Year |
---|---|
Room tilt illusion in Parkinson's disease: loss of spatial reference frames?
Topics: Aged; Amantadine; Antiparkinson Agents; Dopamine Agents; Humans; Illusions; Levodopa; Male; Orientation; Parietal Lobe; Parkinson Disease; Perceptual Disorders; Psychomotor Performance; Space Perception; Tomography, Emission-Computed, Single-Photon; Visual Cortex; Visual Pathways; Visual Perception | 2009 |
Feeling of presence in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Perceptual Disorders; Psychotic Disorders; Surveys and Questionnaires | 2011 |
Dopamine alters tactile perception in Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Dopamine Agents; Female; Humans; Judgment; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Perceptual Disorders; Physical Stimulation; Psychophysics; Retrospective Studies; Touch Perception | 2012 |
"Off" gait freezing and temporal discrimination threshold in patients with Parkinson disease.
Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Perceptual Disorders; Posture; Reflex, Abnormal; Sensory Thresholds; Somatosensory Disorders; Time Perception; Toes; Touch | 2005 |
Diagnostic aspects of early Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Cognition Disorders; Depression; Humans; Levodopa; Parkinson Disease; Perceptual Disorders | 2006 |
[Automatic motion analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations].
Topics: Aged; Antiparkinson Agents; Female; Gait; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Perceptual Disorders; Photic Stimulation | 1996 |
Hypothesis: migraine, a central biochemical dysnociception.
Topics: Adult; Animals; Apomorphine; Circadian Rhythm; Dopamine; Female; Fever; Headache; Humans; Levodopa; Lysergic Acid Diethylamide; Male; Migraine Disorders; Nervous System; Norepinephrine; Pain; Perceptual Disorders; Phenylalanine; Psilocybin; Rats; Reserpine; Serotonin; Sleep; Somatosensory Cortex; Synaptic Transmission | 1976 |
The sixth year after L-dopa: quality of life and insights derived.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Parkinson Disease; Perceptual Disorders; Visual Perception | 1975 |
[Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
Topics: Aged; Benserazide; Drug Therapy, Combination; Female; Form Perception; Humans; Intelligence Tests; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Perceptual Disorders; Problem Solving; Space Perception; Thinking; Visual Perception; Wechsler Scales | 1974 |
Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Drinking Behavior; Electric Stimulation; Electromyography; Feeding and Eating Disorders; Feeding Behavior; Humans; Hydroxydopamines; Levodopa; Motor Neurons; Muscle Contraction; Nerve Degeneration; Neural Pathways; Parkinson Disease; Parkinson Disease, Secondary; Perceptual Disorders; Rats; Reflex, Stretch; Substantia Nigra | 1974 |